… mast cell inhibitor, an angiotensin-converting enzyme inhibitor, … : a population-based, nested
case-control study in Taiwan. … sue inhibitors of matrix metalloproteinase in aortic dissection. …

… angiotensin-converting enzyme inhibitors, anticoagulant agents, antiarrhythmic agents,
beta-blockers, and calcium channel blockers… crossover study based on a large population-based …

… We performed a case-control study in order to investigate the … a role for the angiotensin
converting enzyme (ACE) I/D, but not … therapy was associated with a reduced risk of aortic rupture …

… distinct case control series were examined in this study, … These were the (1) Angiotensin
converting enzyme intron 16 … , ranging from a population-based screening project to a clinical …

… aortic diameter in patients with Marfan syndrome after 6 months therapy with the angiotensin
converting enzyme inhibitor, … due to AAA rupture, as well as adverse events related to study …

… The preferred first line drug for the treatment of hypertension in most of these older patients
is an angiotensin converting enzyme (ACE) inhibitor. All … ACE Inhibitors and aortic rupture …

… This is the first population-based study, 11 to our knowledge, … statins and angiotensin-converting
enzyme (ACE) inhibitors, … study, were associated with a reduction in the risk of rupture. A …

… Angiotensinconverting enzyme inhibitors and aortic rupture: A populationbased case-control
study. Lancet 2006; 368(9536): 659-65. [37] Thompson A, Cooper JA, Fabricius M, …

… agents OR angiotensin-converting enzyme inhibitor OR … of aortic wall weakening and dilatation
and aneurysm rupture. MMP-… In 2019, Morawiec et al [15] conducted a case-control study …

… Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case–control
study… Angiotensin-converting enzyme inhibitors can reduce the wall shear stress and …